Are you seeing any kind of structural shift or softening of the branded pharma market in India maybe because a lot of companies are launching their own trade generics? There has to be some level of cannibalization happening at least on the volume front.
So, it will be fair to assume that in the next three to four years you expect the market to maybe grow at around 10% kind of growth?